Billets de Michelle Dawson

Billet publié sur Twitter/X le 03/12/2012 11:28

Retour aux billets Billet précédent Billet suivant
Twitter/X Essai clinique clinicaltrials.gov Lien intégré au billet Termes sur l’autisme
Ouvrir le billet original

Infos sur le lien intégré au billet

Essai clinique

Hadassah Medical Organization (2014). TSO in Pediatric Autistic Spectrum Disorders. ClinicalTrials.gov. Hadassah Medical Organization.

Plus d’infos

Liens cités structurés

1 ressource citée

Essai clinique Récupéré Publication clinicaltrials.gov

Hadassah Medical Organization (2014). TSO in Pediatric Autistic Spectrum Disorders. ClinicalTrials.gov. Hadassah Medical Organization.

Date de publication
2014
Identifiant
NCT01734941
Auteurs
Hadassah Medical Organization
Source
ClinicalTrials.gov
Type de référence
clinical_trial
Éditeur
Hadassah Medical Organization
Source de métadonnées
clinicaltrials.gov

Résumé

The primary objective of this study is to evaluate and compare the safety and efficacy of Trichuris suis ova (TSO) therapy (versus placebo) in pediatric patients with autism. Evaluation of the safety and tolerability of treatment with TSO in the target population across the dose range being tested is considered a primary objective, while the primary efficacy objective will be assessed via the change from baseline in the Aberrant Behavior Checklist (ABC) subscale scores. Dose response will be considered a primary objective as well. Secondary assessments of efficacy will be assessed via: • The change from baseline in the Clinical Global Impression scale (CGI-I)

Ouvrir la source